Iris Divé[Author] - Search Results

Year	Number of Results
2017	1
2019	2
2020	2
2021	3
2022	2
2023	2
2024	3

1

Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastoma.

Eckhardt A, Drexler R, Schoof M, Struve N, Capper D, Jelgersma C, Onken J, Harter PN, Weber KJ, Divé I, Rothkamm K, Hoffer K, Klumpp L, Ganser K, Petersen C, Ricklefs F, Kriegs M, Schüller U. Eckhardt A, et al. Among authors: dive i. Neuro Oncol. 2024 Mar 4;26(3):503-513. doi: 10.1093/neuonc/noad197. Neuro Oncol. 2024. PMID: 37818983

2

Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.

Luger AL, König S, Samp PF, Urban H, Divé I, Burger MC, Voss M, Franz K, Fokas E, Filipski K, Demes MC, Stenzinger A, Sahm F, Reuss DE, Harter PN, Wagner S, Hattingen E, Wichert J, Lapa C, Fröhling S, Steinbach JP, Ronellenfitsch MW. Luger AL, et al. Among authors: dive i. J Neurooncol. 2022 Sep;159(2):243-259. doi: 10.1007/s11060-022-04049-w. Epub 2022 Jul 21. J Neurooncol. 2022. PMID: 35864412 Free PMC article.

3

Inhibition of mTOR signaling protects human glioma cells from hypoxia-induced cell death in an autophagy-independent manner.

Divé I, Klann K, Michaelis JB, Heinzen D, Steinbach JP, Münch C, Ronellenfitsch MW. Divé I, et al. Cell Death Discov. 2022 Oct 6;8(1):409. doi: 10.1038/s41420-022-01195-y. Cell Death Discov. 2022. PMID: 36202792 Free PMC article.

4

DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.

Drexler R, Schüller U, Eckhardt A, Filipski K, Hartung TI, Harter PN, Divé I, Forster MT, Czabanka M, Jelgersma C, Onken J, Vajkoczy P, Capper D, Siewert C, Sauvigny T, Lamszus K, Westphal M, Dührsen L, Ricklefs FL. Drexler R, et al. Among authors: dive i. Neuro Oncol. 2023 Feb 14;25(2):315-325. doi: 10.1093/neuonc/noac177. Neuro Oncol. 2023. PMID: 35868257 Free PMC article.

5

Activation of Epidermal Growth Factor Receptor Sensitizes Glioblastoma Cells to Hypoxia-Induced Cell Death.

Luger AL, Lorenz NI, Urban H, Divé I, Engel AL, Strassheimer F, Dettmer K, Zeiner PS, Shaid S, Struve N, Kriegs M, Hofmann U, Oefner PJ, Harter PN, Steinbach JP, Ronellenfitsch MW. Luger AL, et al. Among authors: dive i. Cancers (Basel). 2020 Aug 3;12(8):2144. doi: 10.3390/cancers12082144. Cancers (Basel). 2020. PMID: 32756332 Free PMC article.

6

Local Anesthetic-Induced Central Nervous System Toxicity during Interscalene Brachial Plexus Block: A Case Series Study of Three Patients.

Spitzer D, Wenger KJ, Neef V, Divé I, Schaller-Paule MA, Jahnke K, Kell C, Foerch C, Burger MC. Spitzer D, et al. Among authors: dive i. J Clin Med. 2021 Mar 2;10(5):1013. doi: 10.3390/jcm10051013. J Clin Med. 2021. PMID: 33801401 Free PMC article.

7

Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment.

Heinzen D, Divé I, Lorenz NI, Luger AL, Steinbach JP, Ronellenfitsch MW. Heinzen D, et al. Among authors: dive i. Int J Mol Sci. 2019 Sep 10;20(18):4474. doi: 10.3390/ijms20184474. Int J Mol Sci. 2019. PMID: 31510109 Free PMC article.

8

Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death.

Sauer B, Lorenz NI, Divé I, Klann K, Luger AL, Urban H, Schröder JH, Steinbach JP, Münch C, Ronellenfitsch MW. Sauer B, et al. Among authors: dive i. Cell Death Discov. 2024 Jan 5;10(1):8. doi: 10.1038/s41420-023-01779-2. Cell Death Discov. 2024. PMID: 38182566 Free PMC article.

9

Gliomatosis Cerebri Growth Pattern: Association of Differential First-Line Treatment with Overall Survival in WHO Grade II and III Gliomas.

Divé I, Steidl E, Wagner M, Filipski K, Burger MC, Franz K, Harter PN, Bähr O, Fokas E, Herrlinger U, Steinbach JP. Divé I, et al. Oncology. 2021;99(4):215-224. doi: 10.1159/000512562. Epub 2021 Jan 20. Oncology. 2021. PMID: 33472203

10

A 25-year retrospective, single center analysis of 343 WHO grade II/III glioma patients: implications for grading and temozolomide therapy.

Steidl E, Filipski K, Zeiner PS, Wagner M, Fokas E, Forster MT, Ronellenfitsch MW, Divé I, Steinbach JP, Harter PN, Bähr O. Steidl E, et al. Among authors: dive i. J Cancer Res Clin Oncol. 2021 Aug;147(8):2373-2383. doi: 10.1007/s00432-021-03511-y. Epub 2021 Feb 4. J Cancer Res Clin Oncol. 2021. PMID: 33538917 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

15 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year